Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18776604 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL10086041 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18776602 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL22892039 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24245791 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18776606 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24245770 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24245779 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL22892066 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL25812802 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1LMNATHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9644171-B2 | Cyclic acetals and ketals and use thereof as fragrance | SYMRISE AG (DE) | 2017-05-09 | — | — | US | claimed |
| EP-2803666-B1 | Cyclic acetals and ketals and their use as fragrance compounds | SYMRISE AG (DE) | 2016-04-27 | — | — | EP | claimed |
| US-20160090548-A1 | Cyclic Acetals and Ketals and Use Thereof as Fragrance | SYMRISE AG (DE) | 2016-03-31 | — | — | US | claimed |
| US-9644171-B2 | Cyclic acetals and ketals and use thereof as fragrance | SYMRISE AG (DE) | 2017-05-09 | — | — | US | disclosed |
| US-20160090548-A1 | Cyclic Acetals and Ketals and Use Thereof as Fragrance | SYMRISE AG (DE) | 2016-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090548-A1 | Cyclic Acetals and Ketals and Use Thereof as Fragrance | KLK5, KCNK5, KLK1 | ALOX15 3019/4885ALDH1A1 253/4885LMNA 2750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.